DGAP-News: European Healthcare Acquisition & Growth Company B.V.
/ Key word(s): Annual Report
European Healthcare Acquisition & Growth Company B.V. publishes its annual report for the period from 9 July 2021 to 31 December 2021 Amsterdam, 26 April 2022 Today, European Healthcare Acquisition & Growth Company B.V. ("EHC"), a Dutch operators-led special purpose acquisition company listed on Euronext Amsterdam aiming to acquire one or more companies in the European healthcare sector, publishes its annual report for the period from 9 July 2021 to 31 December 2021 (the "Annual Report 2021"), including its financial statements and the report of its board. The Annual Report 2021 can be downloaded from the website of EHC in the 'Investor Relations' section under 'News & Publications': www.ehc-company.com, where a downloadable version in the European Single Electronic Format (ESEF) is also available. On 23 June 2022, EHC will hold its annual general meeting of shareholders (the "AGM"), at which the Annual Report 2021 will be discussed. The agenda of the AGM will be published soon. European Healthcare Acquisition & Growth Company B.V. General Enquiries Disclaimer
26.04.2022 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. |
Language: | English |
Company: | European Healthcare Acquisition & Growth Company B.V. |
c/o ALR Treuhand GmbH; Theresienhöhe 28 | |
80339 München | |
Germany | |
ISIN: | NL0015000K10, NL00115000K28 |
WKN: | A3C60V |
Listed: | Amsterdam |
EQS News ID: | 1336099 |
End of News | DGAP News Service |
|
1336099 26.04.2022
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.